je.st
news
Tag: compared
3 weaning methods compared; which one rises to the top?
2016-08-31 00:04:56| Beef
A study looked at drylot weaning vs. pasture weaning. Which one was the most beneficial to calf health, feedlot performance and finishing? read more
Tags: the
top
methods
compared
Select truck fleets boosted fuel economy 3% in 2015 compared to national Class 8 average
2016-08-28 12:55:22| Green Car Congress
Tags: select
class
national
average
Plastics reduce environmental costs by nearly four times compared to alternatives: report
2016-07-27 00:52:57| Canadian Plastics Headlines
Despite a widespread perception to the contrary, the environmental cost of using plastics in consumer goods and packaging is nearly four times less than if plastics were replaced with alternative materials, a new study reports. The study, by market research… The post Plastics reduce environmental costs by nearly four times compared to alternatives: report appeared first on Canadian Plastics.
CME: US Pork Exports Up Compared with 2015
2016-07-11 02:00:00| ThePigSite - Industry News
US - The USDA’s Economic Research Service (ERS) published May monthly trade numbers for the protein industries last week. This data is based on the US Department of Commerce trade data, write Steve Meyer and Len Steiner.
Tags: with
compared
exports
pork
Mercks KEYTRUDA (pembrolizumab) Demonstrates Superior Progression-Free and Overall Survival Compared to Chemotherapy as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer
2016-06-16 12:45:00| Merck.com - Product News
Dateline City: KENILWORTH, N.J. KEYNOTE-024 Studied Patients Whose Tumors Expressed High Levels of PD-L1 KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the KEYNOTE-024 trial investigating the use of KEYTRUDA (pembrolizumab), in patients with previously untreated advanced non-small cell lung cancer (NSCLC) whose tumors expressed high levels of PD-L1 (tumor proportion score of 50 percent or more), met its primary endpoint. Language: English Contact: MerckMedia:Pamela Eisele, 267-305-3558Courtney Ronaldo, 908-236-1108orInvestors:Teri Loxam, 908-740-1986Justin Holko, 908-740-1879 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: advanced
cell
treatment
compared
Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] next »